Central Bank & Trust’s Enovis ENOV Stock Holding History

Central Bank & Trust’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-393	Closed	-$25.2K	–	336
2023 Q2	$25.2K	Buy	+393	New	+$22.4K	﹤0.01%	248

Other funds holding ENOV

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Central Bank & Trust's ENOV Position: Q3 2023 in Review

Central Bank & Trust sold out of Enovis (ENOV) in Q3 2023, closing a stake of 393 shares — an estimated $25.2K sold.

Central Bank & Trust first reported a position in ENOV in Q2 2023 and held it in 1 quarter. The position peaked at $25.2K in Q2 2023. 267 funds tracked by Wall St. Rank hold ENOV as of Q3 2023.

Central Bank & Trust reported no remaining Enovis position as of Q3 2023 after selling out during the quarter.
Central Bank & Trust sold 393 Enovis shares in Q3 2023, an estimated $25.2K.
Central Bank & Trust first reported a position in Enovis in Q2 2023 and held it in 1 quarter.
Central Bank & Trust's Enovis position peaked at $25.2K in Q2 2023.
267 funds tracked by Wall St. Rank held Enovis as of Q3 2023.

Based on Central Bank & Trust's 13F filing for Q3 2023, filed 10 Oct 2023.